Zoledronic Acid Versus Alendronate In The Treatment of Children With Osteogenesis Imperfecta: A 2-Year Clinical Study

Fang Lv(Liaoning Normal University), Mei Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Weibo Xia(Chinese Academy of Medical Sciences & Peking Union Medical College), Lujiao Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoping Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Liu(ShenZhen People’s Hospital), Yuwen Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Ou Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaojie Xu(Dalian Medical University)
Endocrine Practice
February 1, 2018
10.4158/ep171910.or
Cited by 27

Related Papers

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis
|Bone|2019|110
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles
|Medicine|2017|100